Free Trial
NYSE:ALUR

Allurion Technologies Q3 2023 Earnings Report

Allurion Technologies logo
$2.79 0.00 (0.00%)
Closing price 03:59 PM Eastern
Extended Trading
$3.37 +0.58 (+20.65%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Allurion Technologies EPS Results

Actual EPS
-$54.25
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Allurion Technologies Revenue Results

Actual Revenue
$12.96 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Allurion Technologies Announcement Details

Quarter
Q3 2023
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Allurion Technologies' Q2 2025 earnings is scheduled for Tuesday, August 12, 2025, with a conference call scheduled at 8:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Allurion Technologies Earnings Headlines

Allurion Shares Jump on Weight-Loss Study Results
Do You Believe In President Trump? Answer This 1 Question
They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to Trump’s economic plan. But now there’s a way to protect your retirement without backing down. This free 2025 Wealth Protection Guide reveals how you can use a legal IRS loophole—nicknamed “Piggy Bank”—to shield your savings.
Allurion Technologies (NYSE:ALUR) Upgraded at Wall Street Zen
Roth Capital Has Bullish Estimate for ALUR FY2025 Earnings
See More Allurion Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Allurion Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Allurion Technologies and other key companies, straight to your email.

About Allurion Technologies

Allurion Technologies (NYSE:ALUR) focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.

View Allurion Technologies Profile

More Earnings Resources from MarketBeat